Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fast skeletal troponin C is a calcium-binding regulatory protein found exclusively in fast-twitch (type II) skeletal muscle fibers, encoded by the TNNC2 gene[1][2][3][4][5][6]. It is one of three subunits of the troponin complex (along with troponin I and troponin T) that regulates striated muscle contraction in response to changes in intracellular calcium concentration. Upon Ca^2+^ binding, fast skeletal troponin C (sTnC) undergoes a conformational change that interacts with the troponin I subunit, leading to tropomyosin movement on actin filaments and ultimately permitting actin-myosin cross-bridge cycling and muscle contraction[1][2][5]. Fast skeletal troponin C is homologous but distinct from cardiac and slow skeletal muscle isoforms, with unique structural characteristics and tissue-restricted expression. Mutations in the TNNC2 gene have been implicated in certain congenital myopathies, though sTnC itself is not a common therapeutic target. Some investigational or off-label calcium sensitizers interact with the broader troponin complex but do not selectively target the skeletal isoform[1][3][6].
Calcium sensitization by stabilizing Ca^2+^-bound conformation (for calcium sensitizers targeting troponin complex); Modulation of actin-myosin interaction through troponin complex
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fast skeletal troponin C (sTnC).